C12N 2760/16232
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2760/16232 (Use of virus as therapeutic agent, other than vaccine) appears on 11 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 11
- Published applications
- 13
- Assignees
- 8
- Inventors
- 16
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 2 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 2 | 2 |
| 2010 | 0 | 2 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 2 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of labelling viral particles comprising anionic lipids with fluorescently-labelled negatively-charged polynucleotides in the presence of polyvalent cations21 Apr 2026US 12,607,635 B2Oxford University Innovation Limited
- Fabric top for a convertible vehicle and convertible vehicle16 Jul 2024US 12,036,852 B2Bayerische Motoren Werke Aktiengesellschaft
- Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals12 Jul 2016US 9,387,240 B2Icahn School of Medicine at Mount Sinai
- Methods for the propagation of modified influenza viruses in embryonated eggs31 May 2016US 9,352,033 B2Icahn School of Medicine at Mount Sinai
- Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals1 Jul 2014US 8,765,139 B2Icahn School of Medicine at Mount Sinai
- Cryptic proteins expressed from defective viral genomes interfere with influenza virus replication11 Jul 2024US 2024/0228980 A1Wisconsin Alumni Research Foundation
- Method6 Jan 2022US 2022/0003767 A1Oxford University Innovation Limited
- Fabric Top for a Convertible Vehicle and Convertible Vehicle8 Apr 2021US 2021/0101458 A1Bayerische Motoren Werke Aktiengesellschaft
- Directing Cancer Cells to Self-Destruct Through Vectoring Engineered Viruses6 Jun 2019US 2019/0169636 A1
- Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals29 Sep 2016US 2016/0279227 A1Icahn School of Medicine at Mount Sinai
Most cited
By later US patents
- Methods and interferon deficient substrates for the propagation of viruses37US 6,852,522 B1Mount Sinai School of Medicine of New York University · 2005
- Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals35US 6,669,943 B1Mount Sinai School of Medicine of New York University · 2003
- Methods and interferon deficient substrates for the propagation of viruses34US 6,573,079 B1Mount Sinai School of Medicine of New York University · 2003
- Methods and interferon deficient substrates for the propagation of viruses33US 7,494,808 B2Mount Sinai School of Medicine of New York University · 2009
- Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals15US 7,588,768 B2Mount Sinai School of Medicine of New York University · 2009